Kathy Oubre is the CEO of Pontchartrain Cancer Center in Louisiana.

Kathy is a board member of the Community Oncology Alliance and co-chairs the Drug Policy and Regulatory Affairs committee and serves on their Government Affairs committee. She also serves on the Strategic Advisory committee and Leadership Council for Flatiron Health and is on the Executive Board for Athena Oncology. Kathy is a member of ACCC and serves on their Oral Oncolytics Advisory committee as well as their Government Affairs committee. Additionally, Kathy serves on the editorial boards for The Center for Biosimilars and the Journal of Evidence-Based Managed Care.